The EVAL Non-Adhesive Liquid Embolic Agent is a cutting-edge medical device designed for the treatment of cerebral vascular malformations. It offers a unique combination of materials and delivery mechanisms to ensure precise and effective embolization. The product is composed of a specially formulated EVAL polymer solution and a contrast agent, allowing for clear visualization during the procedure. Its non-adhesive nature ensures that it can be easily controlled and removed if necessary, making it a safe and reliable option for complex vascular treatments.

1. The EVAL Non-Adhesive Liquid Embolic Agent is characterized by its non-adhesive properties, which allow for precise delivery and control during the embolization process. This feature is particularly important in treating delicate vascular structures, where accuracy is crucial.
2. The product's composition includes an EVAL polymer solution, which is a blend of ethylene-vinyl alcohol copolymer, DMSO, and anhydrous ethanol. This combination ensures that the embolic agent remains in a liquid state until it reaches the target area, where it solidifies to form a stable embolus.
3. The primary use of this product is in the treatment of cerebral vascular malformations. It is designed to be delivered through a microcatheter, allowing for precise placement within the vascular system. The inclusion of a contrast agent ensures that the embolic agent can be clearly visualized during the procedure, enhancing the safety and effectiveness of the treatment.

The EVAL Non-Adhesive Liquid Embolic Agent is a sophisticated medical device that combines advanced materials and delivery mechanisms to provide a safe and effective solution for treating cerebral vascular malformations. Its non-adhesive nature and precise delivery system make it an ideal choice for complex vascular procedures, ensuring both safety and efficacy.

The EVAL Non-Adhesive Liquid Embolic Agent offers several key features that make it an effective tool for endovascular embolization. These include its non-adhesive properties, precise delivery system, and clear visualization capabilities.

1. The non-adhesive nature of the EVAL embolic agent allows for precise control during delivery, reducing the risk of unintended embolization and ensuring that the agent can be easily removed if necessary.
2. The product's delivery system includes specially designed syringes and a microcatheter, which allow for accurate placement of the embolic agent within the vascular system. This precision is crucial in treating complex vascular malformations.
3. The inclusion of a contrast agent in the EVAL solution ensures that the embolic agent can be clearly visualized during the procedure. This enhances the safety and effectiveness of the treatment by allowing the physician to monitor the embolization process in real-time.
4. The EVAL polymer solution is designed to remain in a liquid state until it reaches the target area, where it solidifies to form a stable embolus. This ensures that the embolic agent can be precisely delivered and effectively block the targeted blood vessels.
5. The product's composition, including the EVAL polymer and DMSO, is carefully formulated to ensure compatibility with the human body and to minimize the risk of adverse reactions. This makes the EVAL embolic agent a safe and reliable option for endovascular treatments.

The EVAL Non-Adhesive Liquid Embolic Agent is a highly effective tool for endovascular embolization, offering precise control, clear visualization, and a safe, reliable composition. Its advanced features make it an ideal choice for treating complex vascular malformations, ensuring both safety and efficacy.

The EVAL Non-Adhesive Liquid Embolic Agent is primarily used in the clinical treatment of cerebral vascular malformations. Its precise delivery and non-adhesive properties make it an effective tool for endovascular embolization.

1. The EVAL embolic agent is used in the treatment of arteriovenous malformations (AVMs), where it is delivered through a microcatheter to block abnormal blood vessels and prevent further complications.
2. The product is also used in the treatment of cerebral aneurysms, where it can be precisely delivered to the aneurysm sac to promote thrombosis and prevent rupture.
3. In cases of dural arteriovenous fistulas (DAVFs), the EVAL embolic agent is used to block the abnormal connections between arteries and veins, reducing the risk of hemorrhage and other complications.
4. The EVAL embolic agent is also used in the treatment of certain types of tumors, where it can be used to block the blood supply to the tumor, leading to its shrinkage and eventual necrosis.
5. The product's non-adhesive properties make it particularly useful in complex vascular cases, where precise control and the ability to remove the embolic agent if necessary are crucial for patient safety.

The EVAL Non-Adhesive Liquid Embolic Agent is a versatile tool in the clinical treatment of various vascular malformations, including AVMs, aneurysms, and DAVFs. Its precise delivery and non-adhesive properties make it an effective and safe option for endovascular embolization, ensuring positive outcomes for patients.

When purchasing the EVAL Non-Adhesive Liquid Embolic Agent, it is important to consider factors such as product specifications, types, budget, and intended use to ensure the best fit for your clinical needs.

1. Product specifications: Ensure that the EVAL embolic agent meets the required specifications for your clinical application, including the composition, volume, and delivery system.
2. Product types: Consider the different types of EVAL embolic agents available, including variations in the concentration of the EVAL polymer and the type of contrast agent used, to select the most appropriate option for your needs.
3. Budget: Evaluate the cost of the EVAL embolic agent in relation to your budget, taking into account the potential benefits and cost-effectiveness of the product in your clinical practice.
4. Intended use: Consider the specific clinical applications for which the EVAL embolic agent will be used, such as the treatment of AVMs, aneurysms, or DAVFs, to ensure that the product is suitable for your intended use.

Purchasing the EVAL Non-Adhesive Liquid Embolic Agent requires careful consideration of product specifications, types, budget, and intended use. By taking these factors into account, you can ensure that you select the most appropriate product for your clinical needs, maximizing both safety and efficacy.

When using the EVAL Non-Adhesive Liquid Embolic Agent, it is important to follow specific precautions to ensure patient safety and the effectiveness of the treatment.

1. Ensure that the EVAL embolic agent is properly prepared and mixed according to the manufacturer's instructions before use to avoid any potential complications.
2. Use the appropriate delivery system, including the provided syringes and microcatheter, to ensure precise and controlled delivery of the embolic agent to the target area.
3. Monitor the patient closely during and after the procedure for any signs of adverse reactions, such as allergic reactions or embolization of non-target vessels.
4. Follow proper disposal procedures for any unused or expired EVAL embolic agent and related materials to ensure environmental safety and compliance with regulations.
5. Ensure that all personnel involved in the procedure are properly trained in the use of the EVAL embolic agent and are familiar with the potential risks and complications associated with its use.

Using the EVAL Non-Adhesive Liquid Embolic Agent requires careful attention to preparation, delivery, monitoring, and disposal to ensure patient safety and treatment effectiveness. By following these precautions, you can minimize risks and maximize the benefits of this advanced embolic agent.